The diagnosis of prostate cancer is complex, relying on multiple tests rather than a single, definitive diagnostic procedure like the PSA test, which can have unreliable results.
Studies suggest that widespread PSA testing for prostate cancer does not significantly reduce mortality rates, highlighting the need for nuanced discussions between patients and doctors.
Implementing routine PSA screenings for all men isn’t recommended due to variable PSA levels, which can rise from benign conditions or infections, complicating the diagnosis process.
Emerging research considers the integration of MRI scans with PSA testing to enhance diagnostic accuracy, suggesting the medical community is actively seeking better screening methods.
Collection
[
|
...
]